Last reviewed · How we verify

NCT05359978

Treatment in Occupational Therapy With Significant Activities to Improve Quality of Life

Completed NA Last updated 16 May 2022
What this trial tests

NA trial testing To with significance activities in Dementia in 240 participants. Completed in 20 April 2022.

Timeline
1 January 2019
Primary endpoint
20 March 2022
20 April 2022

Quick facts

Lead sponsorUniversidad de Burgos
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingsingle
Primary purposeprevention
Enrollment240
Start date1 January 2019
Primary completion20 March 2022
Estimated completion20 April 2022
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Burgos

Who can join

65 and older, any sex, with Dementia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We followed a pretest-posttest non-equivalent control group experimental design study comparing two cohorts of patient with different types of dementia. Approximately 250 patients will be screened to achieve 240 participants, divided in two cohorts (120 each), furthermore each cohorts was divided in other two groups (experimental group (60 each) and control group (60 each) the first one followed up by private centres in Spain endowed with Occupational Therapy and the second by public centres in the region of Modena.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

Other Universidad de Burgos trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05359978.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing